Oncotelic Therapeutics, Inc.

Oncotelic Therapeutics, Inc.

OTLC - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$6.04M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Oncotelic Therapeutics, Inc.Oncotelic Therapeutics, Inc.0-94%-0.1

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$6.04 Million
Enterprise Value$19.75 Million
Earnings per Share$0.59
Beta-0.21
Outstanding Shares447,386,505

Return

Return on Equity93.55%ROE
Return on Assets62.70%
Return on Invested Capital-1.62%

Valuation & Multiples

P/E Ratio0.02P/E Ratio
PEG0.04PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue78.99
Enterprise Value to EBIT-3.23
Enterprise Value to Net Income0
Total Debt to Enterprise0.7
Debt to Equity0.05Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 18, 2026
EPS Estimate
-$0.02
Consensus analyst estimate
Revenue Estimate
$500,000
Consensus analyst estimate

Next Earnings Call

Expected Date
April 19, 2027
EPS Estimate
-$0.01
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Oncotelic Therapeutics, Inc.

41 employees
CEO: Vuong Trieu

Oncotelic Therapeutics, Inc., an Agoura Hills, California-based clinical-stage biopharmaceutical company, specializes in developing therapeutics for rare oncological conditions. Its flagship therapeutic candidate, OT-101 – an antisense c...

Oncotelic Therapeutics Insider Information FAQ

Stockcircle shows 9 open-market insider purchases for Oncotelic Therapeutics in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.